Full name
"EXTRUDAN" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.90.Z - Non-specialized wholesale trade
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
68.20.Z - Rental and management of own or leased real estate
68.32.Z - Other real estate activities on behalf of third parties
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,2 | 2,9 | 4,8 | 65,2 |
Gross profit (loss) | -0,4 | 2,5 | 4,7 | 89,4 |
EBITDA | 1 | 4,5 | 7 | 56,8 |
Short time liabilities | 4,5 | 4,8 | 2,3 | -51,2 |
Other operating costs | 0 | 0,4 | 0 | -93,8 |
Equity capital | 11,2 | 13,2 | 16,9 | 28,2 |
Operating profit (EBIT) | -0,2 | 2,7 | 4,8 | 81,3 |
Assets | 17,4 | 19 | 19,3 | 1,8 |
Net profit (loss) | -0,4 | 2 | 3,7 | 85,7 |
Cash | 0,1 | 0,1 | 1,7 | 1115,7 |
Net income from sale | 23,7 | 36,3 | 41 | 13 |
Liabilities and provisions for liabilities | 6,2 | 5,8 | 2,5 | -57,8 |
Working assets | 4,8 | 5,7 | 7,2 | 26,7 |
Other income costs | 0 | 0,1 | 0 | -94,7 |
Depreciation | 1,2 | 1,8 | 2,2 | 21 |
% | % | % | p.p. | |
Profitability of capital | -3,7 | 15,2 | 22 | 6,8 |
Equity capital to total assets | 64,3 | 69,3 | 87,3 | 18 |
Gross profit margin | -1,5 | 6,8 | 11,4 | 4,6 |
EBITDA Margin | 4 | 12,3 | 17,1 | 4,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 70 | 48 | 21 | -27 |
Current financial liquidity indicator | 1.0453463792800903 | 1.1916537284851074 | 3.0947251319885254 | 1,9 |
Net dept to EBITDA | 2.407104253768921 | 0.34474068880081177 | -0.2493174523115158 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane